Trial Profile

An Open-Label, Multicenter Study to Evaluate the Safety and Effectiveness of Intravenous CR845 in Hemodialysis Patients with Moderate-to-Severe Pruritus

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Jan 2024 Results assessing the impact of intravenous difelikefalin on HRQoL in haemodialysis patients with moderate-to-severe CKD-aP, published in The Patient - Patient-Centered Outcomes Research
15 Nov 2023 Results of pooled dataset from KALM-1 and KALM-2 and NCT03998163 , evaluating whether itch reduction in CKD-aP improved sleep quality, published in the Nephrology Dialysis Transplantation
21 May 2020 Status changed from active, no longer recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com